Back to Anal Margin Squamous Cell Carcinoma

Anal Margin Squamous Cell Carcinoma — Clinical Trials

MONDO:00014703 active·1 recruitingLast updated: Mar 16, 2026, 2:31 AM

Trial Landscape

Anal Margin Squamous Cell Carcinoma has an emerging clinical trial program, driven by procedure and drug treatment.

Recruiting

Active Trials

By Approach

Procedure3

Drug Treatment2

Biological Therapy2

3 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Phase 2

Phase 3

Sponsor Types

NIH2Collaborative Network1

Trial Locations

United States3 trials

Canada1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

3 Trials

Phase 2Recruiting

NCT04929028

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Aug 2022Est. completion: Sep 2031Updated: Mar 2026

Phase 3Active, Not Recruiting

NCT03233711

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Jul 2018Est. completion: Dec 2027Updated: Mar 2026

Phase 2Active, Not Recruiting

NCT04166318

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Sponsor:ECOG-ACRIN Cancer Research Group

United StatesStarted: Jan 2020Est. completion: Dec 2029Updated: Mar 2026

Stay informed about clinical trials for Anal Margin Squamous Cell Carcinoma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 16, 2026 at 2:31 AM